Penumbra (PEN) Change in Acquisitions & Divestments (2014 - 2026)
Penumbra's (PEN) quarterly Change in Acquisitions & Divestments came in at $125.1 million in Q1 2026, up 862.61% year-on-year from $13.0 million in Q1 2025, and up 862.61% on a QoQ basis from $13.0 million in Q1 2025.
Penumbra (PEN) Change in Acquisitions & Divestments (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 12 years of Change in Acquisitions & Divestments data on file, last reported at $125.1 million in Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments rose 862.61% year-over-year to $125.1 million in Q1 2026; TTM through Mar 2026 was $125.1 million, a 24.84% increase from a year earlier, with the FY2025 full-year figure at $13.0 million, down 90.05% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $125.1 million, up from $13.0 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for PEN reached as high as $125.1 million in Q1 2026 and fell as low as -$59.5 million in Q4 2022.
- Historically, Change in Acquisitions & Divestments has averaged $25.2 million across 5 years, with a median of $19.4 million in 2022.
- Across the five-year window, Change in Acquisitions & Divestments slumped 149.73% in 2022 and surged 862.61% in 2026, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at -$59.5 million in 2022, then jumped by 161.3% to $36.5 million in 2023, then slumped by 86.85% to $4.8 million in 2024, then soared by 170.83% to $13.0 million in 2025, then jumped by 862.61% to $125.1 million in 2026.
- Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $125.1 million in Q1 2026, $13.0 million in Q1 2025, and $4.8 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Penumbra | 12.55 Bn | 11.94 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 125.14 Mn |
| Mar 31, 2026 | 125.14 Mn |
| Mar 31, 2025 | 13.00 Mn |
| Mar 31, 2025 | 13.00 Mn |
| Dec 31, 2024 | 4.80 Mn |
| Dec 31, 2024 | 4.80 Mn |
| Sep 30, 2024 | 42.89 Mn |
| Sep 30, 2024 | 42.89 Mn |
| Jun 30, 2024 | 39.55 Mn |
| Jun 30, 2024 | 39.55 Mn |
| Mar 31, 2024 | 43.38 Mn |
| Mar 31, 2024 | 43.38 Mn |
| Dec 31, 2023 | 36.50 Mn |
| Dec 31, 2023 | 36.50 Mn |
| Sep 30, 2023 | 18.10 Mn |
| Sep 30, 2023 | 18.10 Mn |
| Jun 30, 2023 | 13.37 Mn |
| Jun 30, 2023 | 13.37 Mn |
| Mar 31, 2023 | 14.61 Mn |
| Mar 31, 2023 | 14.61 Mn |